Global and China Primary Biliary Cirrhosis Drug Market Research by Company, Type & Application 2013-2025

Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 Budesonide
    • 1.1.2.2 FFP-104
    • 1.1.2.3 GSK-2330672
    • 1.1.2.4 MBX-8025
    • 1.1.2.5 NGM-282
    • 1.1.2.6 Others
  • 1.1.3 Market by Application
    • 1.1.3.1 Clinic
    • 1.1.3.2 Hospital
    • 1.1.3.3 Others
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 AlbireoPharma
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 CymaBay Therapeutics, Inc.
• 6.3 Dr. Falk Pharma GmbH
• 6.4 Enanta Pharmaceuticals, Inc.
• 6.5 GlaxoSmithKline Plc
• 6.6 Intercept Pharmaceuticals, Inc.
• 6.7 Johnson & Johnson
• 6.8 MediGene AG
• 6.9 NGM Biopharmaceuticals, Inc.
• 6.10 Virobay Inc.

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion